10-Q: Network-1 Technologies Reports Q2 2026 Results, Net Loss Widens

Sentiment:

Quarterly Report


Network-1 Technologies, Inc. reported a wider net loss for the second quarter of 2026, driven by increased operating expenses and no revenue, though a gain from an equity investment provided a partial offset.

Worse than expectedNet loss increased for both the three-month and six-month periods ended June 30, 2026, compared to the same periods in 2025.Revenue was zero for the three and six months ended June 30, 2026, indicating a lack of new licensing or settlement income in the current period.Operating expenses, particularly professional fees and related costs associated with litigation, increased significantly, contributing to the wider net loss.Marketable securities experienced unrealized losses, impacting the overall financial results.

Summary

  • Network-1 Technologies, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026.
  • The company reported a net loss of $655,000 for the three months ended June 30, 2026, compared to a net loss of $463,000 for the same period in 2025.
  • For the six months ended June 30, 2026, the net loss was $1,166,000, an increase from $826,000 in the prior year period.
  • Revenue for both the three-month and six-month periods ended June 30, 2026, was $0, consistent with the prior year's three-month period but a decrease from $150,000 in the prior year's six-month period.
  • Operating expenses increased significantly, from $720,000 in Q2 2025 to $1,013,000 in Q2 2026 for the three-month period, and from $1,515,000 to $2,428,000 for the six-month period.
  • A gain on equity investment of $1,052,000 was recorded in the six months ended June 30, 2026, due to the change in accounting for the ILiAD investment.
  • Cash and cash equivalents decreased to $9,435,000 as of June 30, 2026, from $13,402,000 as of December 31, 2025.
  • The company continues to pursue licensing opportunities for its patent portfolios and review opportunities to acquire additional intellectual property.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to increased net losses, rising operating expenses, and a lack of revenue in the current period, despite a one-time gain from an equity investment.

Positives

  • Recorded a $1,052,000 gain on equity investment in ILiAD Biotechnologies, Inc. during the six months ended June 30, 2026, due to a change in accounting method following a financing round.
  • The company has $33,752,000 in cash and cash equivalents and marketable securities as of June 30, 2026, providing sufficient liquidity for the next twelve months and the foreseeable future.
  • The U.S. Patent Trial and Appeal Board (PTAB) denied the institution of six Inter Partes Review proceedings requested by Samsung, which is positive for the ongoing litigation.
  • The U.S. Court of Appeals for the Federal Circuit overturned a lower court's judgment of non-infringement for one of the company's patents against Google's Content ID system, remanding the case for further proceedings.
  • The company has an active share repurchase program with $4,777,417 remaining capacity as of June 30, 2026.

Negatives

  • Reported zero revenue for the three and six months ended June 30, 2026.
  • Net loss increased to $655,000 for Q2 2026 from $463,000 in Q2 2025, and to $1,166,000 for the first six months of 2026 from $826,000 in the same period of 2025.
  • Operating expenses increased by $293,000 to $1,013,000 for Q2 2026 compared to Q2 2025, and by $913,000 to $2,428,000 for the first six months of 2026 compared to 2025, primarily due to increased litigation costs.
  • Interest and dividend income decreased due to lower funds available for investment and lower yields.
  • Realized and unrealized losses on marketable securities were $279,000 for the first six months of 2026, compared to gains of $171,000 in the prior year period, reflecting a decline in market value.
  • Deferred tax expense increased significantly to $245,000 for the first six months of 2026, compared to a benefit of $149,000 in the prior year period, partly due to the gain on the equity investment.
  • Cash and cash equivalents decreased by $3,967,000 during the first six months of 2026.

Risks

  • Uncertainty of revenue from licensing intellectual property.
  • Uncertainty of the outcome of pending litigations.
  • Ability to achieve future revenue from patent portfolios.
  • Ability to protect patents.
  • Ability to execute strategy to acquire or invest in high-quality patents with significant licensing opportunities.
  • Ability to enter into strategic relationships to license or monetize third-party intellectual property.
  • Potential determination as a personal holding company in 2026 or future years, which could result in a special cash dividend and less cash for operations.
  • Legislative, regulatory, and competitive developments.

Future Outlook

The company believes it will have sufficient liquidity to fund operations for the next twelve months and the foreseeable future. Future revenue is dependent on monetizing its patent portfolios and achieving a successful outcome from its investment in ILiAD. The company anticipates continuing its semi-annual cash dividend policy of $0.05 per share, but this is subject to review and change.

Management Comments

  • "Our principal business is the development, licensing and protection of our intellectual property assets."
  • "Our future revenue is dependent on our ability to monetize our M2M/IOT Patent Portfolio, HFT Patent Portfolio, Cox Patent Portfolio and Smart Home Patent Portfolio. If we are unable to successfully monetize such patent portfolios or achieve a successful outcome of our investment in ILiAD, our business, financial condition and results of operations will be negatively impacted."
  • "Our current strategy includes continuing our licensing efforts with respect to our intellectual property assets and the monetization of our patent portfolios."
  • "In 2026 and future years we could be classified as a Personal Holding Company. If this is the case, we would be subject to a 20% tax on the amount of any undistributed personal holding company income (as defined) for such year that we do not distribute to our shareholders."
  • "At this time, we anticipate continuing to pay dividends consistent with our policy. However, our dividend policy undergoes a periodic review by our Board of Directors and is subject to change at any time depending upon our financial requirements, earnings and other factors existing at the time."

Industry Context

StockSavvy.ai notes that Network-1 Technologies operates in the intellectual property licensing sector, a field characterized by long-term value generation through patent protection and strategic enforcement. The company's focus on specific technology areas like M2M/IoT, HFT, and Smart Home reflects trends in technological advancement and the increasing importance of specialized IP. The significant increase in operating expenses, largely due to litigation costs, is a common challenge for IP monetization companies, highlighting the high stakes and resource intensity of patent assertion.

Legal Proceedings

  • Patent litigation commenced against Optiver US, LLC and Optiver Trading US, LLC for infringement of HFT Patent Portfolio patents.
  • Patent litigation commenced against Samsung Electronics Co., LTD and Samsung Electronics America, Inc. for infringement of M2M/IoT Patent Portfolio patents; trial date scheduled for June 7, 2027.
  • Patent litigations initiated against Citadel Securities, LLC and Jump Trading, LLC for infringement of HFT Patent Portfolio patents; Citadel's motion to dismiss denied, Citadel filed answer; Jump Trading case dismissed without prejudice.
  • Patent infringement claims against Google Inc. and YouTube, LLC related to Cox Patent Portfolio patents; Federal Circuit overturned lower court's non-infringement judgment for one patent, remanded for further proceedings; trial date scheduled for December 7, 2026.

Stakeholder Impact

  • Shareholders: Increased net loss per share may negatively impact investor sentiment. Continued dividend payments provide some return, but the dividend policy is subject to change.
  • Creditors: No long-term debt is reported, reducing direct creditor risk.
  • Employees: Stock-based compensation continues, impacting equity and potentially employee incentives.
  • Suppliers/Service Providers: Increased professional fees and related costs suggest higher spending on legal and other services.

Next Steps

  • Continue pursuing licensing opportunities for its patent portfolios.
  • Review opportunities to acquire additional intellectual property.
  • Continue working with inventors and patent owners to assist in development and monetization of their patented technologies.
  • Potentially enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.
  • Continue patent litigation efforts.
  • Monitor the investment in ILiAD Biotechnologies, Inc. for potential returns.
  • The company may issue a special cash dividend if determined to be a Personal Holding Company.

Key Dates

DateDescription
2011-08-01Inception of Share Repurchase Program.
2013-02-04Acquisition of Cox Patent Portfolio.
2017-12-01Acquisition of M2M/IoT Patent Portfolio.
2022-03-01Employment agreement with Chairman and Chief Executive Officer entered into.
2022-08-01Acquisition of HFT Patent Portfolio.
2022-09-20Stockholders approved the 2022 Stock Incentive Plan.
2024-12-24Initiated patent litigation against Citadel Securities, LLC and Jump Trading, LLC.
2025-03-13Annual Report on Form 10-K for the year ended December 31, 2025 filed.
2025-03-25Patent Purchase Agreement related to HFT Patent Portfolio.
2025-03-31Acquisition of Smart Home Patent Portfolio.
2025-04-07Citadel filed a motion to dismiss and Jump Trading filed an answer in patent litigation.
2025-04-23U.S. Court of Appeals for the Federal Circuit issued a decision on the appeal against Google Inc. and YouTube, LLC.
2025-05-19PTAB denied institution of IPRs filed by Citadel.
2025-06-02PTAB denied institution of IPRs filed by Citadel.
2025-06-17Board of Directors authorized extension and increase of share repurchase program.
2025-06-27Commenced patent litigation against Samsung Electronics Co., LTD.
2025-07-01Dismissed patent infringement case against Jump Trading, LLC without prejudice.
2025-09-08Commenced patent litigation against Optiver US, LLC and Optiver Trading US, LLC.
2025-11-21Optiver defendants filed answer and counterclaims.
2026-01-05Citadel filed its answer in patent litigation.
2026-02-05ILiAD Biotechnologies, Inc. completed Series B preferred stock financing and converted to a corporation.
2026-04-23U.S. Court of Appeals for the Federal Circuit issued a decision on the appeal against Google Inc. and YouTube, LLC.
2026-05-19PTAB denied institution of IPRs filed by Citadel.
2026-06-02PTAB denied institution of IPRs filed by Citadel.
2026-06-29Entered into a written trading plan (10b5-1 Plan) for share repurchases.
2026-06-30Quarterly period ended.
2026-08-03Number of shares of common stock outstanding as of this date.
2026-08-06Report signed by CEO and CFO.

Recommendation

hold

The company's financial performance shows a worsening net loss and no revenue in the current period, which is a significant concern. However, the substantial cash reserves, the potential upside from ongoing patent litigations (especially the positive development in the Google case), and the one-time gain from the ILiAD investment provide some stability and potential for future recovery. The 'hold' recommendation reflects a balance between the current negative financial trends and the speculative potential of its intellectual property assets.

Keywords

intellectual property, patent licensing, patent litigation, M2M/IoT, HFT, Smart Home, equity investment, marketable securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.